Potential dengue treatment safe for patients; further tests needed on dose and effectiveness
Published on Jul 30, 2014 5:32 PM
SINGAPORE - Researchers from the Singapore General Hospital and Duke-NUS Graduate Medical School Singapore have found that Celgosivir, a potential dengue treatment, is generally safe for patients.
But further tests need to be done to determine how often it should be taken.
Celgosivir is derived from a naturally occurring compound found in the seeds of the Moreton Bay Chestnut tree.
The team's earlier laboratory tests found it worked against all four types of dengue but studies remain to be done on how much of it and how often it should be given to patients. Though recent human tests prove that it was safe, patients who took 200mg of Celgosivir twice a day for four days, following an initial 400mg dose, did not recover from dengue fever any faster.
To continue reading, log in if you are a subscriber
If you are not a subscriber, you can get instant, unlimited access here